Utidelone capsules(Biostar)

优替德隆胶囊（华昊中天）

Report date: 2026/03/04 20:01:44

Base Information

Drug NameUtidelone capsules(Biostar)
Drug Alias NameDepoxythilone优替德隆胶囊（2.2改良型）
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitosis inhibitorsTubulin polymerisation inhibitors
TargetsTubulin
Therapy Area/IndicationsMetastatic breast cancerGastroesophageal Junction NeoplasmsSolid tumours +[16] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesChengdu Biostar Pharmaceuticals LtdBeijing Biostar Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Biostar Pharmaceuticals LtdBeijing Biostar Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerGastroesophageal Junction NeoplasmsSolid tumours +[16] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank